Jayson Rieger's most recent trade in Verrica Pharmaceuticals Inc was a trade of 850,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Verrica Pharmaceuticals Inc | Jayson Rieger | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 850,000 | 850,000 | - | - | Employee Stock Option (right to buy) | |
Verrica Pharmaceuticals Inc | Jayson Rieger | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2024 | 280,898 | 832,826 (3%) | 1% | - | Common Stock | |
Verrica Pharmaceuticals Inc | Jayson Rieger | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2024 | 140,449 | 140,449 | - | - | Series B Warrants (right to buy) | |
Verrica Pharmaceuticals Inc | Jayson Rieger | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2024 | 140,449 | 140,449 | - | - | Series A Warrants (right to buy) | |
Verrica Pharmaceuticals Inc | Jayson Rieger | Director, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Nov 2024 | 50,000 | 882,826 (3%) | 0% | 0 | Common Stock | |
Verrica Pharmaceuticals Inc | Jayson Rieger | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 2,000,000 | 2,000,000 | - | - | Employee Stock Option (right to buy) |